JURIST Supported by the University of Pittsburgh
PAPER CHASE NEWSBURSTDigest RSS feedFull RSS feed
Serious law. Primary sources. Global perspective.


Monday, November 08, 2004

Merck subject of DOJ, SEC probes over Vioxx
Tom Henry at 8:07 PM ET

[JURIST] Pharmaceutical giant Merck and Co., maker of the recalled pain reliever drug Vioxx, said Monday it had been served a subpoena by the US Department of Justice and that it is also the subject of an inquiry by the Securities and Exchange Commission. Merck began a voluntary worldwide withdrawal of the drug, which had entered the market in 1999, on September 30, 2004. As of October 31, Merck says it has been named in about 375 lawsuits, including state consumer fraud and fair business practice cases. Merck maintains a website on its voluntary Vioxx withdrawal here. Reuters has more.






Link |  | print | subscribe | RSS feeds | latest newscast | Facebook page

For more legal news check the Paper Chase Archive...


LATEST LEGAL NEWS

 UK judge upholds request to withhold evidence in Russian spy death investigation
5:26 PM ET, May 19

 Afghanistan parliament blocks women's rights legislation
4:06 PM ET, May 19

 Cameroon authorities urged to drop charges against transgender youths
11:45 AM ET, May 19

 click for more...

Get JURIST legal news delivered daily to your e-mail!

LATEST FORUM

In Alabama, "Back Door" Restrictions on Abortion and Roe
DOMESTIC
LaJuana Davis
Cumberland School of Law

ABOUT

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible, ad-free format.

CONTACT

Paper Chase welcomes comments, tips and URLs from readers. E-mail us at JURIST@jurist.org